1. Home
  2. COEP vs BGI Comparison

COEP vs BGI Comparison

Compare COEP & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • BGI
  • Stock Information
  • Founded
  • COEP 2017
  • BGI 1879
  • Country
  • COEP United States
  • BGI Canada
  • Employees
  • COEP N/A
  • BGI N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • BGI
  • Sector
  • COEP Health Care
  • BGI
  • Exchange
  • COEP Nasdaq
  • BGI Nasdaq
  • Market Cap
  • COEP 32.4M
  • BGI 26.4M
  • IPO Year
  • COEP N/A
  • BGI 2005
  • Fundamental
  • Price
  • COEP $12.31
  • BGI $1.07
  • Analyst Decision
  • COEP
  • BGI
  • Analyst Count
  • COEP 0
  • BGI 0
  • Target Price
  • COEP N/A
  • BGI N/A
  • AVG Volume (30 Days)
  • COEP 121.3K
  • BGI 350.1K
  • Earning Date
  • COEP 03-25-2025
  • BGI 11-27-2024
  • Dividend Yield
  • COEP N/A
  • BGI N/A
  • EPS Growth
  • COEP N/A
  • BGI N/A
  • EPS
  • COEP N/A
  • BGI N/A
  • Revenue
  • COEP N/A
  • BGI $131,596,264.00
  • Revenue This Year
  • COEP N/A
  • BGI N/A
  • Revenue Next Year
  • COEP N/A
  • BGI N/A
  • P/E Ratio
  • COEP N/A
  • BGI N/A
  • Revenue Growth
  • COEP N/A
  • BGI 4.01
  • 52 Week Low
  • COEP $2.31
  • BGI $1.03
  • 52 Week High
  • COEP $13.70
  • BGI $3.98
  • Technical
  • Relative Strength Index (RSI)
  • COEP 62.60
  • BGI 26.81
  • Support Level
  • COEP $8.65
  • BGI $1.32
  • Resistance Level
  • COEP $13.70
  • BGI $1.54
  • Average True Range (ATR)
  • COEP 1.89
  • BGI 0.21
  • MACD
  • COEP -0.21
  • BGI -0.05
  • Stochastic Oscillator
  • COEP 72.48
  • BGI 3.99

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

Share on Social Networks: